Current trends in cancer immunotherapy: a literature-mining analysis

Cancer Immunol Immunother. 2020 Dec;69(12):2425-2439. doi: 10.1007/s00262-020-02630-8. Epub 2020 Jun 15.

Abstract

Cancer immunotherapy is a rapidly growing field that is completely transforming oncology care. Mining this knowledge base for biomedically important information is becoming increasingly challenging, due to the expanding number of scientific publications, and the dynamic evolution of this subject with time. In this study, we have employed a literature-mining approach that was used to analyze the cancer immunotherapy-related publications listed in PubMed and quantify emerging trends. A total of 93,033 publications published in 5055 journals have been retrieved, and 141 meaningful topics have been identified, which were further classified into eight distinct categories. Statistical analysis indicates a mean annual increase in the number of published papers of approximately 8% in the last 20 years. The research topics that exhibited the highest trends included "immune checkpoint inhibitors," "tumor microenvironment," "HPV vaccination," "CAR T-cells," and "gene mutations/tumor profiling." The top identified cancer types included "lung," "colorectal," and "breast cancer," and a shift in popularity from hematological to solid tumors was observed. As regards clinical research, a transition from early phase clinical trials to randomized control trials was recorded, indicating that the field is entering a more advanced phase of development. Overall, this mining approach provided an unbiased analysis of the cancer immunotherapy literature in a time-conserving and scale-efficient manner.

Keywords: Cancer immunotherapy; LDA; Literature mining; Topic modeling; Trends analysis.

Publication types

  • Systematic Review

MeSH terms

  • Antineoplastic Agents, Immunological / therapeutic use
  • Bibliometrics*
  • Cancer Vaccines / therapeutic use
  • Data Mining
  • Humans
  • Immunotherapy / methods
  • Immunotherapy / trends*
  • Mutation
  • Neoplasms / genetics
  • Neoplasms / immunology
  • Neoplasms / therapy*
  • Papillomavirus Vaccines / therapeutic use
  • PubMed / statistics & numerical data
  • Randomized Controlled Trials as Topic

Substances

  • Antineoplastic Agents, Immunological
  • Cancer Vaccines
  • Papillomavirus Vaccines